Pulmonary arterial hypertension: open trials in Mexico

• NCT07179380

  Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Trial Treatment · Phase 3 · Insmed Incorporated

  MEX003, Mexico City · MEX001, Monterrey · MEX002, Monterrey

  Registry updated 2026-10-26

• NCT06274801

  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Trial Treatment · Phase 3 · Gossamer Bio USA, Inc.

  Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City · Unidad de Investigacion Clinica en Medicina, S.C., Monterrey

  Registry updated 2026-10-13

• NCT03683186

  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Trial Treatment · Phase 3 · United Therapeutics

  CICUM San Miguel, Guadalajara · Instituto Nacional de Ciencias Médicas y Nutricion Dr. Salvador Zubiran, Mexico City · Instituto Nacional de Cardiologia Dr Ignacio Chavez Rivera, Mexico City · Unidad de Investigacion Clinica en Medicina, S.C., Monterrey

  Registry updated 2026-10-06

• NCT06649110

  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals

  Monterrey · San Luis Potosí City

  Registry updated 2026-07-21

• NCT05665556

  REgistry of Pulmonary Arterial Hypertension Associated With CONNECTIVE Tissue Diseases (RECONNECTIVE)

  Research · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

  Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City

  Registry updated 2023-06-29

All Pulmonary arterial hypertension trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error